Why Synthetic CBD Is (Probably) the Future of Cannabis Pharma
The first company to create and patent a CBD compound will have a serious edge in this fast-growing industry.
Most cannabis producers are busy growing plants, but scientists at biotech companies are actively developing what they believe could be the future of the industry: It’s “synthetic” CBD, created in the lab.
Because the synthetic cannabinoid could cut the massive costs of cultivating the crop and quicken the FDA approval process, the quest has taken hold especially among medical marijuana pharmaceutical companies focused on developing new drugs. Already, researchers, universities, and a handful of startups are in the early stages of synthesizing cannabis’s CBD. But the first company to actually patent a compound (or the process to make it) in a way that’s both therapeutic and scalable would command a serious edge in this fast-growing industry.
Continue reading this article -- and everything on Entrepreneur!
Become a member to get unlimited access and support the voices you want to hear more from. Get full access to Entrepreneur for just $5!
3 months free with code ZENDESK
Presented by zendesk